Angela Dispenzieri, M.D.

  1. Hematologist
  • Multiple myeloma
  • Monoclonal gammopathy
  • Cryoglobulinemia
  • Osteosclerotic myeloma and POEMS syndrome
  • Amyloidosis
  1. 1998
    Fellow - Hematology and OncologyMayo Graduate School of Medicine, Mayo Clinic College of Medicine
  2. 1994
    ResidentMayo Graduate School of Medicine, Mayo Clinic College of Medicine
  3. 1991
    MDAlbert Einstein College of Medicine
  4. 1985
    BS - BiologyMassachusetts Institute of Technology

Certifications

  1. 1997
    HematologyAmerican Board of Internal Medicine

Awards and honors

  1. 2016
    Serene M. and Frances C. Durling ProfessorshipMayo Clinic Board of Governors, Mayo Clinic Committees
  2. 1997
    Genetics in OncologyFirst Annual Workshop, Berlex Oncology Foundation
  3. 1996
    Epidemiology and Clinical Trial DesignFourth Annual Workshop, Berlex Oncology Foundation
  4. 1992
    Associates Clinical Vignette CompetitionAmerican College of Physicians

Professional memberships

  1. 2019 - present
    MemberMayo Clinic Research Core Subcommittee
  2. 2018 - present
    Immediate Past PresidentInternational Society of Amyloidosis
  3. 2018 - present
    MemberPerformance Expectations for Clinical Trialists Taskforce
  4. 2017 - present
    MemberSociety of Hematologic Oncology (SOHO); SOHO Education Committee
  5. 2017 - present
    RepresentativeClinical Research Subcommittee, Mayo Clinic Committees
  6. 2017 - present
    MemberMayo Clinic Research Committee, Mayo Clinic Committees
  7. 2016 - 2017
    Track LeaderAmerican Society of Clinical Oncology
  8. 2016 - 2018
    PresidentInternational Society of Amyloidosis
  9. 2015 - present
    MemberAmyloidosis Research Consortium Steering Committee
  10. 2014 - present
    ChairASH Scientific Committee on Lymphoid Neoplasia
  11. 2014 - present
    Vice ChairClinical Trials Subcommittee, Institutional Research Committee, Mayo Clinic Committees
  12. 2014 - 2016
    President-ElectInternational Society of Amyloidosis
  13. 2014
    Advisory Board MemberMulticentric Castleman's Disease (MCD) Current Treatment Practices (CTP)
  14. 2013 - present
    TreasurerInternational Myeloma Society
  15. 2013 - present
    MemberCastleman Disease Collaborative Network Scientific Advisory Board
  16. 2011
    CouncilorASH Scientific Committee on Lymphoid Neoplasia
  17. 2011 - present
    MemberASH Scientific Committee on Lymphoid Neoplasia
  18. 2010 - 2014
    TreasurerInternational Society of Amyloidosis
  19. 2010 - 2013
    Co-ChairCIBMTR Plasma Cell Disorders Working Committee, ABMTR/IBMTR
  20. 2010 - 2013
    Co-ChairPlasma Cell Disorders Committee, ABMTR/IBMTR
  21. 2010 - 2011
    MemberMayo Clinic Workstation Oversight Subcommittee.
  22. 2008 - present
    MemberCIBMTR Plasma Cell Disorders Working Committee, ABMTR/IBMTR
  23. 2008 - present
    Associate ChairPriorities of Laboratory Testing Committee, Mayo Clinic Rochester Committees
  24. 2007 - present
    MemberContinuing Medical Education, Mayo Foundation for Medical Education and Research
  25. 2005 - present
    MemberPriorities of Laboratory Testing Committee, Mayo Clinic Rochester Committees
  26. 2004 - 2007
    ChairScientific Oversight Committee, Mayo Clinic Cancer Center Committees, Mayo Clinic Cancer Center
  27. 2004 - present
    MemberMayo Clinic Cancer Center
  28. 2004 - present
    MemberHematology Clinical Practice Committee, Division of Hematology, Department of Internal Medicine
  29. 2002 - present
    Associate ChairHematology Research, Division of Hematology, Department of Internal Medicine
  30. 1999 - 2002
    Associate Program DirectorHematology Education Committee, Division of Hematology, Department of Internal Medicine
  31. 1999 - present
    MemberABMTR/IBMTR
  32. 1998 - 2002
    MemberHematology Education Committee, Division of Hematology, Department of Internal Medicine
  33. 1998 - present
    MemberDivision of Hematology, Department of Internal Medicine
  34. 1998 - 1999
    MemberHematology Test Questions, American Board of Internal Medicine
  35. 1998 - present
    MemberAmerican Society of Hematology
  36. 1998 - present
    MemberAmerican Society of Clinical Oncology
  37. 1998 - present
    MemberAmerican Medical Association
  38. 1998 - present
    MemberNorth Central Cancer Treatment Group
  39. 1998 - present
    MemberEastern Cooperative Oncology Group
  40. 1989 - 1999
    Invited AuthorHematology Test Questions, American Board of Internal Medicine
  41.  
    MemberPriorities of Laboratory Testing Subcommittee, Clinical Practice Committee - Rochester, Mayo Clinic Rochester Committees
see more

Publications

Research activities

See a description of research activities.